Company Filing History:
2 out of 2,198 
1 out of 832,843 Years Active: 2000-2002
Title: Philip Szekeres: Innovator in HNEAA81 Receptor Research
Introduction
Philip Szekeres is a notable inventor based in Roydon, GB. He has made significant contributions to the field of biochemistry, particularly in the study of the HNEAA81 receptor. With a total of 2 patents, his work focuses on developing methods for screening agonists and antagonists that can lead to advancements in medical treatments.
Latest Patents
Szekeres' latest patents include innovative methods for screening for agonists and antagonists of the HNEAA81 receptor. These patents detail the production of HNEAA81 polypeptides and polynucleotides through recombinant techniques. His research aims to design protocols for treating various infections, including those caused by HIV-1 and HIV-2, as well as addressing conditions such as pain, cancers, and neurological disorders.
Career Highlights
Throughout his career, Philip Szekeres has worked with prominent organizations, including Smithkline Beecham Corporation. His experience in these companies has contributed to his expertise in the field of receptor research and therapeutic development.
Collaborations
Szekeres has collaborated with notable professionals in his field, including Ganesh Madhusudan Sathe and Wendy S. Halsey. These collaborations have likely enriched his research and expanded the impact of his innovations.
Conclusion
Philip Szekeres stands out as an influential inventor in the realm of biochemistry, particularly with his work on the HNEAA81 receptor. His patents and collaborations reflect his commitment to advancing medical science and improving treatment protocols for various health conditions.